Story
European Stocks Attempt Rebound After Mideast Tensions Trigger Sharp Sell-Off
Summary
The pan-European STOXX 600 gained in early trading, attempting to recover from its worst single-day loss in nearly four months after a U.S.-Iran escalation fueled a spike in oil prices and renewed inflation concerns.
European equities edged higher Thursday, attempting to find a footing after a sharp geopolitical flare-up in the Middle East triggered the region's worst market rout in months. The recovery follows a session where resurgent inflation fears rattled investors.
The pan-European STOXX 600 index was up 0.5% in early trade. The move comes after the benchmark plunged 1.6% on Wednesday, its steepest single-day percentage drop since mid-March, which pushed the index to a nearly two-week low.
Geopolitical Shock Roils Markets
The sell-off was sparked by a sudden escalation in U.S.-Iran tensions. According to reports, U.S. President Donald Trump declared an interim ceasefire agreement was "over," followed by U.S. Central Command launching a second day of air strikes against military infrastructure in Iran. The actions were reportedly in response to alleged Iranian targeting of commercial vessels in the Strait of Hormuz, a critical chokepoint for global oil transit.
The geopolitical instability shattered recent market calm, causing a spike in crude oil prices and sending investors away from riskier assets. On Thursday, major European bourses showed a mixed but cautiously positive response:
- Germany's DAX gained 0.7%
- France's CAC 40 rose 0.6%
- Italy's FTSE MIB climbed 0.8%
- London's FTSE 100 was an outlier, falling 0.2%
AdInflation Fears Resurface
While the immediate catalyst is geopolitical, the primary concern spooking investors is the macroeconomic fallout. A sustained spike in energy prices threatens to reignite cost-push inflation, complicating the policy path for major central banks.
The development challenges the recent neutral stances of the European Central Bank (ECB) and the Bank of England. As a result, the "higher-for-longer" interest rate narrative has returned to the forefront, putting pressure on fixed-income markets. Sovereign bond yields, which move inversely to prices, remained elevated on Thursday.
Corporate Movers
Among individual companies, shares of pharmaceutical firm AstraZeneca fell sharply by 9% after the company announced a late-stage trial for a nerve disease drug did not meet its primary endpoint. In contrast, Germany's Schott Pharma saw its stock jump 20% following the release of its financial results.